VSIQQ
DEAD

Serial Number

79314850

Owner

NOVARTIS AG

Attorney

Maury M. Tepper, III

Filing Date

May 20, 2021

Add to watchlist:

No watchlists yet
View on USPTO

VSIQQ Trademark

Serial Number: 79314850

VSIQQ is a trademark filed by NOVARTIS AG on May 20, 2021. The trademark is classified under Class 5 (Pharmaceuticals). The application is currently no longer active.

Owner Contact Info

NOVARTIS AG (7,171 trademarks)

CH-4002
BASEL , CH

Entity Type: 03

Trademark Details

Filing Date

May 20, 2021

Registration Date

Not Registered

Goods & Services

Anti-infectives; anti-inflammatories; antibacterial pharmaceuticals; antibiotics; antifungal preparations; antivirals; cardiovascular pharmaceuticals; dermatological pharmaceutical preparations; inhaled pharmaceutical preparations for the prevention and treatment of respiratory diseases and disorders; pharmaceutical preparations acting on the central nervous system; pharmaceutical preparations and substances for the prevention and treatment of gastro-intestinal diseases; pharmaceutical preparations for the prevention and treatment of diseases and disorders of the autoimmune system, the metabolic system, the endocrine system, the musculo-skeletal system and the genitourinary system; pharmaceutical preparations for use in hematology and in tissue and organ transplantation; pharmaceutical preparations for the prevention and treatment of eye diseases and conditions; pharmaceutical preparations for the prevention and treatment of heart rhythm disorders; pharmaceutical preparations for the prevention and treatment of immune system related diseases and disorders; pharmaceutical preparations for the prevention and treatment of kidney diseases; pharmaceutical preparations for the prevention and treatment of diabetes; pharmaceutical preparations for the prevention and treatment of hypertension; pharmaceutical preparations for the prevention and treatment of skin disorders; pharmaceutical preparations for use in dermatology; pharmaceutical preparations for use in urology; pharmaceutical preparations for use in ophthalmology; pharmaceutical preparations for the prevention and treatment of cancer and tumors; pharmaceutical preparations for the prevention and treatment of allergies; pharmaceutical preparations for the prevention and treatment of bone diseases; pharmaceutical preparations for the prevention and treatment of respiratory diseases and asthma

Filing History

NOTIFICATION OF EFFECT OF CANCELLATION OF INTL REG E-MAILED
Apr 21, 2025 DENA
DEATH OF INTERNATIONAL REGISTRATION
Apr 21, 2025 DETH
FINAL DECISION TRANSACTION PROCESSED BY IB
Jun 19, 2023 FINT
FINAL DISPOSITION NOTICE SENT TO IB
Jun 1, 2023 FICS
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Jun 1, 2023 FICR
NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB
Dec 27, 2022 OPNX
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Dec 7, 2022 OPNS
NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB
Dec 7, 2022 OPNR
ABANDONMENT NOTICE E-MAILED - FAILURE TO RESPOND
Jun 1, 2022 MAB2
ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE
Jun 1, 2022 ABN2
ASSIGNED TO EXAMINER
Jan 10, 2022 DOCK
REFUSAL PROCESSED BY IB
Dec 12, 2021 RFNT
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Nov 18, 2021 RFCS
REFUSAL PROCESSED BY MPU
Nov 18, 2021 RFRR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Oct 22, 2021 RFCR
NON-FINAL ACTION WRITTEN
Oct 21, 2021 CNRT
NON-FINAL ACTION (IB REFUSAL) WITHDRAWN FOR REVIEW
Oct 21, 2021 RFWR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Sep 28, 2021 RFCR
NON-FINAL ACTION WRITTEN
Sep 27, 2021 CNRT
ASSIGNED TO EXAMINER
Sep 20, 2021 DOCK
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Aug 16, 2021 CHAN
TEAS CHANGE OF CORRESPONDENCE RECEIVED
Aug 16, 2021 TCCA
TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS
Aug 16, 2021 ECDR
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Aug 16, 2021 ARAA
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Aug 16, 2021 REAP
TEAS CHANGE OF OWNER ADDRESS RECEIVED
Aug 16, 2021 COAR
APPLICATION FILING RECEIPT MAILED
Jul 20, 2021 MAFR
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Jul 15, 2021 NWOS
LIMITATION FROM ORIGINAL APPLICATION ENTERED
Jul 12, 2021 LIMI
SN ASSIGNED FOR SECT 66A SUBSEQ DESIG FROM IB
Jul 1, 2021 SDRC